Objective: To conduct the first employer/workplace survey identifying employment opportunities for graduates of programs with training in public health genetics in the USA, and to determine whether employment opportunities will increase in coming years. Methods: Six public health genetics training competencies were developed. A survey about workplace and employment opportunities was then conducted with mailings to (1) departments in schools of public health and departments of preventive medicine, (2) local and regional public health officials, (3) insurance companies and health management organizations (HMOs), and (4) biotechnology and pharmaceutical companies. Results: A total of 196 surveys were returned among 1,464 that were mailed. Response rates varied from 5.8 to 46.5% among the target groups. The percent of responding organizations currently employing individuals with skills in genetics ranged from 20 to 62%. The percent currently employing individuals with skills in public health ranged from 39 to 96%. Training opportunities such as internships or practicum experiences are reported for one-third of respondents. For all of the competencies, approximately half of survey respondents who rated the competency important or very important already employ individuals with public health genetics skills. Similarly, at least a quarter of survey respondents who rated the competency important or very important plan to hire individuals with that skill in the next 5 years. Overall, approximately 40% of those surveyed are planning to hire individuals with competencies in public health genetics in the next 5 years. Conclusion: Employment opportunities already exist and new positions are becoming available in schools of public health and departments of preventive medicine, departments of public health, insurance companies and HMOs for professionals with public health genetics training. Based on our survey findings, skills and training in public health genetics are important in the workplace.

1.
Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al: The sequence of the human genome. Science 2001;291:1304–1351.
2.
International Human Genome Sequencing Consortium: Initial sequencing and analysis of the human genome. Nature 2001;409:860–921.
3.
Omenn GS: Public health genetics: An emerging interdisciplinary field for the post-genomic era. Annu Rev Public Health 2000;21:1–13.
4.
Khoury MJ, Burke W, Thomson EJ: Genetics and public health: A framework for the integration of human genetics into public health practice; in Khoury MJ, Burke W, Thomson EJ (eds): Genetics and Public Health in the 21st Century. New York, Oxford University Press, 2000, pp 3–23.
5.
Holtzman NA, Marteau TM: Will genetics revolutionize medicine? N Engl J Med 2000;343:141–144.
6.
Burris S, Gostin LO, Tress D: Public health surveillance of genetic information: Ethical and legal responses to social risk; in Khoury MJ, Burke W, Thomson EJ (eds): Genetics and Public Health in the 21st Century. New York, Oxford University Press, 2000, pp 527–546.
7.
Clayton EW: Genetics, public health, and the law; in Khoury MJ, Burke W, Thomson EJ (eds): Genetics and Public Health in the 21st Century. New York, Oxford University Press, 2000, pp 489–505.
8.
Press N, Clayton EW: Genetics and public health: Informed consent beyond the clinical encounter; in Khoury MJ, Burke W, Thomson EJ (eds): Genetics and Public Health in the 21st Century. New York, Oxford University Press, 2000, pp 505–526.
9.
Austin MA, Peyser PA, Khoury MJ: The interface of genetics and public health: Research and educational challenges. Annu Rev Public Health 2000;21:81–99.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.